Literature DB >> 8102299

Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.

J M Cheng1, J L Hiemstra, S S Schneider, A Naumova, N K Cheung, S L Cohn, L Diller, C Sapienza, G M Brodeur.   

Abstract

Genomic imprinting plays a role in influencing the parental origin of genes involved in cancer-specific rearrangements. We have analysed 22 neuroblastomas with N-myc amplification to determine the parental origin of the amplified N-myc allele and the allele that is deleted from chromosome 1p. We analysed DNA from neuroblastoma patients and their parents, using four polymorphisms for 1p and three for the N-myc amplicon. We determined that the paternal allele of N-myc was preferentially amplified (12 out of 13 cases; P = 0.002). However, the paternal allele was lost from 1p in six out of ten cases, consistent with a random distribution (P > 0.2). These results suggest that parental imprinting influences which N-myc allele is amplified in neuroblastomas, but it does not appear to affect the 1p allele that is deleted in the cases that we have examined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102299     DOI: 10.1038/ng0693-191

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  11 in total

1.  MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.

Authors:  Saif Zaman; Boris I Chobrutskiy; George Blanck
Journal:  Cell Cycle       Date:  2018-11-18       Impact factor: 4.534

Review 2.  Genomic imprinting: mechanism and role in human pathology.

Authors:  B Tycko
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

3.  Clinical characteristics of infant neuroblastoma and a summary of treatment outcome.

Authors:  Yi Zhang; Dongsheng Huang; Weiling Zhang; Suoqin Tang; Tao Han; Xia Zhu; Aiping Liu; Tian Zhi
Journal:  Oncol Lett       Date:  2016-11-04       Impact factor: 2.967

4.  Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.

Authors:  H Caron; P van Sluis; N van Roy; J de Kraker; F Speleman; P A Voûte; A Westerveld; R Slater; R Versteeg
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

5.  Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.

Authors:  H Caron; P van Sluis; R Buschman; R Pereira do Tanque; P Maes; L Beks; J de Kraker; P A Voûte; G Vergnaud; A Westerveld; R Slater; R Versteeg
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

6.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

Review 7.  PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.

Authors:  Palanisamy Nallasamy; Srinivas Chava; Sumit S Verma; Shruti Mishra; Santhi Gorantla; Don W Coulter; Siddappa N Byrareddy; Surinder K Batra; Subash C Gupta; Kishore B Challagundla
Journal:  Semin Cancer Biol       Date:  2017-11-28       Impact factor: 15.707

8.  miR-34a inhibits the apoptosis of MDSCs by suppressing the expression of N-myc.

Authors:  Si Chen; Anfei Huang; Huo Chen; Yi Yang; Fei Xia; Liping Jin; Jinping Zhang
Journal:  Immunol Cell Biol       Date:  2016-02-01       Impact factor: 5.126

9.  Integrative multi-omics module network inference with Lemon-Tree.

Authors:  Eric Bonnet; Laurence Calzone; Tom Michoel
Journal:  PLoS Comput Biol       Date:  2015-02-13       Impact factor: 4.475

10.  A miRNA catalogue and ncRNA annotation of the short-living fish Nothobranchius furzeri.

Authors:  Mario Baumgart; Emanuel Barth; Aurora Savino; Marco Groth; Philipp Koch; Andreas Petzold; Ivan Arisi; Matthias Platzer; Manja Marz; Alessandro Cellerino
Journal:  BMC Genomics       Date:  2017-09-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.